A deep dive with an Experian partner, DeepIntent

by Andy.Monte@experian.com 8 min read July 17, 2026

At A Glance

Pharma marketers can support more informed health journeys when patient and HCP messaging is relevant, privacy-forward, and optimized against meaningful outcomes. In this Ask the Expert conversation, Experian and DeepIntent discuss how health marketers can coordinate education, CTV, activation workflows, and measurement without entering private clinical decisions.

Privacy-forward pharma media supports more informed healthcare journeys

Effective pharma marketing depends on reaching patients, caregivers, and healthcare professionals (HCPs) with useful information in appropriate, privacy-forward ways. The goal is to make relevant education easier to find, support more informed conversations, and help brands understand how media contributes across the health journey.

In this Ask the Expert session, Natalie Mancuso, SVP, Data Partnerships at DeepIntent, joins Sheila Wirick, who leads the health team at Experian, to discuss how to craft patient and HCP campaigns, privacy-safe activation workflows, connected TV (CTV), and measurement approaches built for pharma.

Why should your media plan start with understanding the patient and provider

The patient-and-provider journey should inform your media plan, as treatment decisions in pharma are increasingly informed, personal, and patient-driven. With more health information available than ever, patients are playing a more active role in understanding their options and participating in treatment conversations. As other industries become more customer-centric, pharma media planning needs to become more patient-centric.

“We’ve got patients who are more informed, more involved in their treatment decisions than ever. The accessibility of data and information and the ways we can consume it with just AI alone is so vast that if we’re not arming people with the right information in real time, we’re missing the boat.”

DeepIntentNatalie Mancuso, SVP, Data Partnerships

This means media should be aligned to where a patient or provider is in the decision journey and what they need at that moment. Early on, media may play an educational role by building awareness of a condition, symptom, or treatment category. Later, it may help support more specific questions, treatment consideration, access, affordability, or adherence.

The patient-provider conversation remains the key boundary. That exchange should stay private and clinically led. Media can play a valuable role before and after those moments by offering information that helps patients and providers feel more informed.

How can brands connect patient and HCP messaging responsibly?

It’s critical for agencies and brands to deliver relevant messaging to inform each stakeholder’s needs throughout the treatment journey, especially ahead of key clinical milestones. To execute this, brands must exercise privacy-forward activation, keeping patient and HCP identity, activation, and measurement paths separate, while using a common workflow layer to support the same brand goal.

Two illustrationts. On the left is an illustration of a man with short hair with a mobile phone icon. On the right is an illustration of a man in a white coat with a laptop icon.

Experian helps pharma marketers do this by acting as an independent, privacy-forward identity, data, and workflow layer. We bring together high-fidelity matching, governed onboarding, and non-clinical consumer context, so patient and HCP engagement can be activated more accurately across channels and connected to reporting.

The distinction is not only where each audience is reached. HCPs may be engaged in both professional and personal environments, but their needs are different from patients’. For example, an HCP may receive messaging about co-pay savings for eligible patients, while a patient may receive information about patient support programs. These are different messages for different audiences, but they ladder up to the same goal: informing both parties in a privacy-forward, relevant way.

Hear from Natalie Mancuso in our 2026 State of advertising report

In our 2026 State of advertising report, Natalie shares why identity serves as the connective infrastructure that links planning, activation, and measurement across connected TV (CTV), programmatic, commerce media, and walled garden environments.

What does privacy-forward activation look like in pharma?

Pharma brands often start with fragmented patient and HCP signals. Privacy-forward activation turns those inputs into usable audiences by first confirming that the data can be used, then translating identity in controlled environments that protect personally identifiable information through tokenization or other methodologies.

A privacy shield icon surrounded by four icons: a magnifying class, a patient chart, a bar graph, and four interlocking squares.

For DTC, that means building and matching audiences without relying on inferred health conditions from browsing behavior. For HCPs, it means connecting professional identity to verified sources in a way that supports activation and measurement. In a category shaped by HIPAA, state privacy laws, internal review, and consumer sensitivity, building privacy in from sourcing through activation is what makes responsible health media possible.

How can CTV play a more useful role in pharma?

CTV can play a more useful role in healthcare when it’s connected to a larger, privacy-forward plan and not treated as just an awareness channel.

An icon of a CTV connected to email, location, and home icons

DeepIntent connects CTV and digital exposure data using identity signals, such as National Provider Identifiers (NPIs), hashed email addresses, IP addresses, device IDs, and household signals, where permitted and reviewed. That identity layer helps support sequencing and suppression across streaming, endemic, mobile, and digital settings.

In practice, CTV can introduce targeted education or broad brand awareness, and later touchpoints can provide sequential information in the right channels. Instead of repeating the same message, brands can make pivots based on engagement and context.

“For us, it starts with identity and not panels. When we’re resolving CTV and digital exposures to the same person, we’re leveraging signals so that every touchpoint across streaming, endemic, and mobile is recognized as the same individual, not model lookalikes.”

DeepIntentNatalie Mancuso, SVP, Data Partnerships

For pharma, campaign performance should not be measured by reach alone. A stronger approach looks at whether sequenced engagement contributes to meaningful downstream signals, including:

  • Prescription activity
  • Provider engagement
  • Referral patterns
  • Patient compliance
  • Adherence signals, where measurement is permitted

Why should messaging and reporting change in pharma?

Pharma campaigns are journeys with changing information needs. Reporting should guide the campaign optimization.

“If I’m launching into a market with a new class of drug, I’m asking what education needs to be put into the market – from both an HCP and a consumer standpoint – to build awareness?”

DeepIntentNatalie Mancuso, SVP, Data Partnerships

Clicks and website visits still have a place, but they can’t tell the full pharma story. DeepIntent processes data in real time, giving brands an up-to-date read on how media connects to campaign engagement. Campaign signals can help teams optimize audience logic, creative, channel mix, or sequencing during a live campaign.

Allison O'Mealia headshot

Heading Test for Media & Text Block

Content Test for Media &Text Block

Allison O'Mealia headshot

Heading Test for Media & Text Block

Content Test for Media &Text Block

Allison O'Mealia headshot

Heading Test for Media & Text Block

Content Test for Media &Text Block

Explore how privacy-safe pharma activation can make an impact

Experian brings marketing data and identity expertise for health marketing and DeepIntent adds pharma-specific activation experience. Together, we help brands connect patient and HCP strategies responsibly, with privacy built in from the start.

A doctor speaks to a patient with four icons next to the patient that represent the heart, medicine, stethoscope, and digital health

Watch the full video with our experts to hear Sheila Wirick and Natalie Mancuso discuss patient and HCP messaging, CTV, privacy-safe activation, and outcome measurement for pharma brands.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


About our experts

Natalie Mancuso

SVP, Data Partnerships, DeepIntent

Natalie Mancuso is SVP, Data Partnerships at DeepIntent and a leader in health-focused AdTech and DSP strategy. With over 20 years of experience growing billion-dollar healthcare brands, she turns complex data into scalable, performance-driven solutions that keep marketers ahead of industry change.

Sheila Wirick

Director of Health Sales, Experian

Sheila Wirick is the Director of Health Sales at Experian with more than 20 years of experience in data and analytics. As Director of Health Sales at Experian Marketing Services, she collaborates with healthcare, pharmaceutical, and nonprofit organizations to apply data and insights that enhance customer retention, brand awareness, and acquisition. She is committed to helping organizations use data to deliver measurable results and meaningful impact.


FAQs

A pharma audience is activation-ready when patient or HCP inputs can be translated into usable audiences with the right accuracy, controls, interoperability, and destination readiness. For patient engagement, that may include privacy-safe cohort construction, caregiver logic, non-clinical enrichment and appropriate exclusion rules. For HCP engagement, it may include governed identity inputs such as NPI, specialty, practice location, professional address and other verified attributes where appropriate.

Pharma brands can sequence messages responsibly by giving each channel a clear role and using audience logic to maintain continuity. CTV and out-of-home can support awareness, social can reinforce the message, search can capture active research and point-of-care or rep-triggered channels can support decision moments. The workflow should preserve separation between patient and HCP identity strategies.

Pharma marketers should measure whether media connects to outcomes such as audience quality, prescription activity, qualified HCP engagement, verified delivery, referral patterns, therapy starts or adherence signals where permitted. These outcomes often depend on partner-enabled workflows, clean rooms, and aggregated outputs rather than direct end-to-end tracking.

Experian acts as an independent privacy-first identity, data, and workflow layer for pharma marketers. We help brands bring together identity, high-fidelity matching, governed onboarding, non-clinical consumer context, and partner interoperability so patient and HCP engagement can be activated more accurately across channels and connected more cleanly to partner-enabled measurement.


Latest posts

On April 22nd, Americans and many of their terrestrial counterparts in countries around the world will celebrate Earth Day, a tradition that was started in the United States by Wisconsin Senator Gaylord Nelson in 1970. Much has changed on the planet since the first Earth Day, and even in recent years attitudes continue to evolve when it comes to our outlook towards the environment. In 2007, Experian Simmons created the GreenAware consumer segmentation, which classified respondents to the Simmons National Consumer Study between 2005 until 2007 into one of four mutually exclusive segments based on their consumer behaviors and attitudes toward the environment. Since then, Experian Simmons has continuously classified all adult respondents into the GreenAware segments providing our clients with valuable insights into the evolution of the environmental movement. The four GreenAware segments are: Behavioral Greens: This group of people thinks and acts green. They have negative attitudes towards products that pollute and incorporate green practices into their lives on a regular basis. Think Greens: This group of consumers think green, but don’t always act green. Potential Greens: This group neither behaves, nor thinks along particularly environmentally conscious lines and remains on the fence about key green issues. True Browns: They are not environmentally conscious, and may in fact have negative attitudes about environmental issues. Since 2005, we have observed a nearly constant increase in the percent of U.S. adults who are classified as Behavioral Greens, the “greenest” segment of the four. Today, 33% of adults are Behavioral Greens, up from 27% who were classified as such in 2005. Meantime, Think Greens have maintained an almost perfectly constant 21% share of the population. The size of the True Browns segment has also remained constant at between 14% and 15% of the total adult population. The Potential Green segment, however, has steadily declined in market share from 39% in 2005 to 31% today. La Vida Verde Hispanic Americans have traditionally been ahead of the curve when it comes to green thoughts and deeds and they’re only getting greener with time. Today, 39% of Hispanic adults are Behavioral Greens, up from 33% in 2007. Just 32% of non-Hispanic adults are Behavioral Greens today, up from 29% who fell into the greenest segment in 2007. Interestingly, among the True Browns segment there are virtually no Hispanics to be found, and, in fact, while the True Brown population is actually growing among non-Hispanics, Hispanics are increasingly moving to greener segments. Specifically, just 1.3% of Hispanics are True Browns today, down from 8% who registered as such in 2007. By comparison, 17% of non-Hispanics are True Browns today, up from 14% in 2007. Green Today, Greener Tomorrow? The illustration below shows the alignment of America’s largest metropolitan areas with the four GreenAware segments today and in 2007. We see that residents of the San Francisco-, New York- and Miami-areas are the most likely to be in alignment with the Behavioral Green mindset today. Denizens of Washington, D.C., Los Angeles, Chicago, Philadelphia and Boston tend to fit more closely with the Think Green set that has green attitudes and intentions, but not always the actions to back it up. But things are changing. In fact, since 2007, we’ve seen that as local minds change, some cities become aligned with a different, often greener, segment. Let’s look at Chicago, for instance. In 2007, Chicagoans’ environmental outlook was more reflective of a mix of Potential Greens and True Browns. Since then, local attitudes have changed so much that Chicago-area residents are now more aligned with Think Greens and Behavioral Greens. Likewise, Cleveland, which was clearly a True Brown town in 2007, now falls in step with the Potential Green segment. In five years’ time, who knows? Cleveland could be America’s next green leader. Not brown now towns Looking at markets large and small with the biggest drop in concentration of True Browns, we see that attitudes in inland markets located in Gulf States have become disproportionately less brown since the Deepwater Horizon oil spill in 2010. In fact, seven of the ten Designated Market Areas (DMA) that saw the biggest decline in the percentage of their population classified as True Browns between 2007 and 2011 are inland markets in states bordering the Gulf of Mexico. While the oil didn’t directly reach these markets, the attitude change did spread: For example, 3.2% of adults residing in the Columbus-Tupelo-West Point, Mississippi DMA today are classified as True Browns, down from 19.3% who were categorized as such in 2007. In Macon, Georgia, while not a Gulf State, a more impressive shift took place. In 2007, the Macon, Georgia DMA had the fourth highest percentage of its population classified as True Browns (20.1%) out of 209 DMAs. Today, only 5.8% of area residents are True Browns, which makes it the market with the 10th lowest concentrations of True Browns in the nation. Macon still has one of the lowest shares of residents who are Behavioral Greens in the nation, but what a difference a few years makes. While the towns directly in the path of the oil spill are not among those with the biggest relative decline in True Browns, area residents’ attitudes did take on a greener hue since the spill. Today, 8.4% of residents in Panama City are True Browns down from 17.3% in 2007. Likewise, only 9.8% of adults in both the Mobile-Pensacola and Biloxi Gulfport DMAs are True Browns down from 17.3% and 19.0%, respectively, who fell into the least green segment prior to the spill. Learn more about Experian Simmons consumer segmentation offerings

April 17, 2012 by Experian Marketing Services

Long gone are the days of preparing our taxes the old-fashioned way using pen and paper (and hopefully a calculator). Last year, just 8.7% of U.S. tax filers prepared their taxes manually, down from 16.4% of filers who prepared their taxes this way in 2006. Software (including both online and offline versions, such as Turbo Tax or H&R Block At Home) have risen to replace their graphite-powered ancestors. In 2005, 21.5% of tax filers said they used software to prepare their taxes. Specifically, 6.8% used offline software and another 14.7% used online software.

April 10, 2012 by Experian Marketing Services

Yesterday, Facebook announced the acquisition of Instagram, a popular photo sharing network with over 30 million users, for $1 billion. Visits to the Instagram website have steadily increased over the past 24 weeks and reached 3.8 million last…

April 10, 2012 by Experian Marketing Services

Subscribe to our newsletter

Enter your name and email for the latest updates

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

About Experian Marketing Services

At Experian Marketing Services, we use data and insights to help brands have more meaningful interactions with people. As leaders in the evolution of the advertising landscape, Experian Marketing Services can help you identify your customers and the right potential customers, uncover the most appropriate communication channels, develop messages that resonate, and measure the effectiveness of marketing activities and campaigns.

Visit our website

Subscribe to our newsletter

Stay up to date on the latest industry news and receive expert tips from our marketing experts.
Subscribe now!